1-2 of 2
Patrick Goubert
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preexisting Insulin Autoantibodies Predict Efficacy of Otelixizumab in Preserving Residual β-Cell Function in Recent-Onset Type 1 Diabetes

Simke Demeester, Bart Keymeulen, Leonard Kaufman, Annelien Van Dalem, Eric V. Balti, Ursule Van de Velde, Patrick Goubert, Katrijn Verhaeghen, Howard W. Davidson, Janet M. Wenzlau, Ilse Weets, Daniel G. Pipeleers, Frans K. Gorus
Journal: Diabetes Care
Diabetes Care 2015;38(4):644–651
https://doi.org/10.2337/dc14-1575
Published: 12 January 2015
View articletitled, Preexisting Insulin Autoantibodies Predict Efficacy of Otelixizumab in Preserving Residual β-Cell Function in Recent-Onset Type 1 Diabetes
Open the PDF for Preexisting Insulin Autoantibodies Predict Efficacy of Otelixizumab in Preserving Residual β-Cell Function in Recent-Onset Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

Associations of GAD65- and IA-2-Autoantibodies With Genetic Risk Markers in New-Onset IDDM Patients and Their Siblings. The Belgian Diabetes Registry

Christina L Vandewalle, MD, Alberto Falorni, MD, PHD, Åke Lernmark, MD, PHD, Patrick Goubert, Harry Dorchy, MD, PHD, Willy Coucke, MD, Crispin Semakula, MD, Bart Van Der Auwera, MD, Leon Kaufman, MSC, PHD, Frans C Schuit, MD, PHD, Daniël G Pipeleers, MD, PHD, Frans K Gorus, MD, PHD
Journal: Diabetes Care
Diabetes Care 1997;20(10):1547–1552
https://doi.org/10.2337/diacare.20.10.1547
Published: 01 October 1997
View articletitled, Associations of GAD65- and IA-2-Autoantibodies With Genetic Risk Markers in New-Onset IDDM Patients and Their Siblings. The Belgian Diabetes Registry
Open the PDF for Associations of GAD65- and IA-2-Autoantibodies With Genetic Risk Markers in New-Onset IDDM Patients and Their Siblings. The Belgian Diabetes Registry in another window